NYSE: RDY

DR Reddys Laboratories Ltd. (RDY)

DR Reddys Laboratories Ltd. is a public company that reports to the U.S. Securities and Exchange Commission and trades on NYSE under the ticker RDY. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
RDY
Exchange
NYSE
SEC CIK
1135951
Official filings
SEC EDGAR

Research RDY

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is DR Reddys Laboratories Ltd.'s stock ticker?

DR Reddys Laboratories Ltd. trades under the ticker symbol RDY on NYSE. Its SEC Central Index Key (CIK) is 1135951.

Where can I read DR Reddys Laboratories Ltd.'s SEC filings?

The RDY SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports DR Reddys Laboratories Ltd. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze RDY's financial statements?

The RDY Financials page shows DR Reddys Laboratories Ltd.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does RDY compare with its peers and the market?

The RDY Peer Comparison page lines DR Reddys Laboratories Ltd. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.